Kiwi firm's trial adds weight in obesity market | Herald NOW Business
Brief
Calocurb CEO Sarah Kennedy discusses the company's ambitions to scale its plant-based weight-loss product in a market dominated by pharmaceutical giants.
In-depth
Calocurb CEO Sarah Kennedy discusses the company's ambitions to scale its plant-based weight-loss product in a market dominated by pharmaceutical giants.
More from NZ Herald